Skip to content
Lower risk Medical device recall · FDA · Published January 11, 2024

Micro Therapeutics Apollo Onyx Microcatheter Recall: Different US Indications for Use

Micro Therapeutics recalls Apollo Onyx Delivery Microcatheter (AOMC) sold in US with different indications for use than European version. This may lead to improper medical use. Contact for details.

🇺🇸 FDA recall #Z-1253-2024Medical deviceMicro Therapeutics ›
Take action

Contact the company

Recalling firmMicro Therapeutics, Inc.9775 Toledo Way · Irvine, CA 92618-1811
✎ GovInfoNow plain-language explainer

Micro Therapeutics is recalling a specific type of medical catheter sold in the US that has different intended medical uses than the European version. This could lead to improper medical procedures if used without understanding the correct indications. Read more at govinfonow.com/recall/56331-micro-therapeutics-apollo-onyx-microcatheter-recall-different-us-indications-for.

Source Summary by GovInfoNow · govinfonow.com/recall/56331-micro-therapeutics-apollo-onyx-microcatheter-recall-different-us-indications-for · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1253-2024

Cite this page

“Micro Therapeutics Apollo Onyx Microcatheter Recall: Different US Indications for Use.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56331-micro-therapeutics-apollo-onyx-microcatheter-recall-different-us-indications-for. Based on FDA recall #Z-1253-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1253-2024%22&limit=1).

The FDA announced on Jan. 11, 2024, that Micro Therapeutics, Inc. is recalling the Apollo Onyx Delivery Microcatheter because European versions distributed in the U.S. contain different indications for use. The recall affects 95 units nationwide.

How to tell if you have it

  • Brand: Micro Therapeutics
  • Product: The Apollo Onyx Delivery Microcatheter (AOMC)
  • UDI: 00763000311445
  • Lot codes: B510758, B555761, B615024, B615025, B629693, B629694

The hazard

The European version of the microcatheter was distributed within the U.S. and contains a different "Indications for Use" than intended for the U.S. market.

Context

GovInfoNow's records show Micro Therapeutics, Inc. has had six other recalls on record since July 13, 2021. Other recent recalls of similar products include Medline Medical Procedure Kits Recall: Catheter Issues (May 4, 2026) and Microvention Bobby Balloon Guide Catheter Recall: Balloon Pinhole Defects (April 30, 2026).

How to tell if you have this one

Check for the UDI code 00763000311445 and lot numbers B510758, B555761, B615024, B615025, B629693, B629694 on the catheter packaging or label.

  • Brand
    Micro Therapeutics
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KS, MA, MD, MI, MO, NC, ND, NE, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI.
Recall numberProduct, codes & lotsQuantity
Z-1252-2024The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole catheter designed for the infusion of the Onyx liquid embolic system (LES). The catheter has a semi-rigid proximal shaft and a highly flexible distal shaft to facilitate the advancement of the catheter in the anatomy. The proximal end of the catheter incorporates a standard Luer adapter to facilitate the attachment of accessories. The outer diameter surface of the catheter is hydrophilically coated to increase lubricity. The AOMC is designed to facilitate catheter retrieval in the event the catheter becomes entrapped within the vasculature. The distal section of the catheter incorporates a detachment zone that allows detachment of the distal tip when the force required to extract the catheter exceeds the force to detach the tip. The catheter has two radiopaque marker bands to visualize the position of the catheter and the detach zone area, one proximal to the detach zone and one at the distal end of the catheter.; UDI: 00763000311438/ Lot # B510757, B593510, B61068982 units
Z-1253-2024The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole catheter designed for the infusion of the Onyx liquid embolic system (LES). The catheter has a semi-rigid proximal shaft and a highly flexible distal shaft to facilitate the advancement of the catheter in the anatomy. The proximal end of the catheter incorporates a standard Luer adapter to facilitate the attachment of accessories. The outer diameter surface of the catheter is hydrophilically coated to increase lubricity. The AOMC is designed to facilitate catheter retrieval in the event the catheter becomes entrapped within the vasculature. The distal section of the catheter incorporates a detachment zone that allows detachment of the distal tip when the force required to extract the catheter exceeds the force to detach the tip. The catheter has two radiopaque marker bands to visualize the position of the catheter and the detach zone area, one proximal to the detach zone and one at the distal end of the catheter.; UDI: 00763000311445/ Lot # B510758, B555761, B615024, B615025, B629693, B62969495 units
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the UDI code 00763000311445 and lot numbers B510758, B555761, B615024, B615025, B629693, B629694 on the catheter packaging or label.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 30 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: nationwideCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KS, MA, MD, MI, MO, NC, ND, NE, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Maryland, Massachusetts, Michigan, Missouri, Nebraska, Nevada, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Jan 11, 202412. FDA classified it Class II: Mar 4, 202423. Published in FDA’s Enforcement Report: Mar 13, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury?

The recall is due to a difference in intended medical uses between the US and European versions, not a direct risk of serious injury. The danger level is low risk.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1253-2024 (January 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1253-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA